Finance

Lister
ALMKT:EPA
Mauna Kea Technologies SA
0,092ย โ‚ฌ
+1,43%
(+0,0013) 1ย D
17. nov., 17:35:06 GMT+1  ·   EUR
Alle symboler
SymbolPrisEndringEndring (%)
Genererer viktig statistikk for ALMKTย โ€ฆ
ร…pne
0,09ย โ‚ฌ
Hรธy
0,09ย โ‚ฌ
Lav
0,09ย โ‚ฌ
Markedsverdi
18,30ย mill.
Snittvolum
478,35k
Volum
396,59k
P/E-forhold
0,79
52ย u hรธy
0,23ย โ‚ฌ
52ย u lav
0,07ย โ‚ฌ
EPS
0,12ย โ‚ฌ
Utestรฅende aksjer
195,26ย mill.
Antall ansatte
56
ร…pne
0,09ย โ‚ฌ
Hรธy
0,09ย โ‚ฌ
Lav
0,09ย โ‚ฌ
Markedsverdi
18,30ย mill.
Snittvolum
478,35k
Volum
396,59k
P/E-forhold
0,79
52ย u hรธy
0,23ย โ‚ฌ
52ย u lav
0,07ย โ‚ฌ
EPS
0,12ย โ‚ฌ
Utestรฅende aksjer
195,26ย mill.
Antall ansatte
56
Nyhetssaker
Fra nettkilder og nyhetspartnere
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts. The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time. Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Om Mauna Kea Technologies SA
Administrerende direktรธrSacha Loiseau
Ansatte56
Grunnlagt2000
Hovedkontor-
SektorHealth Care
Bransje-
Siste rapport
21. juli 2026
Regnskapsperiode
kvartal2 2026
- / -
Omsetning/anslag (EUR)
1,75ย mill. / -
Resultatpresentasjon for K2 2026.
Venter pรฅ resultatpresentasjonen
Kort fortalt
Statistikk fra de siste nyhetene og rapportene
Tidligere rapporterAlle verdier i EUR
Loading Previous Earnings...
Inntekt
Nettoinntekt
Alle verdier i EUR
sep. 2025
des. 2025
mars 2026
juni 2026
Inntekt
2,44ย mill.
2,44ย mill.
1,75ย mill.
1,75ย mill.
Varekostnad
528,00k
528,00k
494,50k
494,50k
Direkte driftskostnader
528,00k
528,00k
494,50k
494,50k
Utgifter til forskning og utvikling
861,00k
861,00k
796,00k
796,00k
Totale kostnader til forskning og utvikling
-
-
-
-
Salgskostnader, generelle kostnader og administrative kostnader
1,89ย mill.
1,89ย mill.
2,13ย mill.
2,13ย mill.
Driftskostnader
3,11ย mill.
3,11ย mill.
3,33ย mill.
3,33ย mill.
Totale driftskostnader
3,64ย mill.
3,64ย mill.
3,83ย mill.
3,83ย mill.
Driftsinntekter
โˆ’1,20ย mill.
โˆ’1,20ย mill.
โˆ’2,08ย mill.
โˆ’2,08ย mill.
Andre ikke-operasjonelle inntekter
10,84ย mill.
10,84ย mill.
โˆ’236,00k
โˆ’236,00k
EBT inkludert uvanlige elementer
7,69ย mill.
7,69ย mill.
โˆ’2,41ย mill.
โˆ’2,41ย mill.
EBT uten uvanlige elementer
8,06ย mill.
8,06ย mill.
โˆ’2,41ย mill.
โˆ’2,41ย mill.
Kostnad for inntektsskatt
โˆ’35,50k
โˆ’35,50k
-
-
Faktisk avgiftssats
โˆ’0,46ย %
โˆ’0,46ย %
-
-
Andre driftskostnader
92,00k
92,00k
95,00k
95,00k
Nettoinntekt
7,72ย mill.
7,72ย mill.
โˆ’2,41ย mill.
โˆ’2,41ย mill.
Netto fortjenestemargin
316,50ย %
316,50ย %
โˆ’137,65ย %
โˆ’137,65ย %
Resultat per aksje
-
-
-
-
Rente- og investeringsinntekter
-
-
-
-
Rentekostnader
โˆ’490,50k
โˆ’490,50k
โˆ’25,50k
โˆ’25,50k
Netto rentekostnader
โˆ’490,50k
โˆ’490,50k
โˆ’25,50k
โˆ’25,50k
Avskrivnings- og amortiseringskostnader
-
-
-
-
EBITDA
โˆ’1,11ย mill.
โˆ’1,11ย mill.
โˆ’2,04ย mill.
โˆ’2,04ย mill.
Gevinst eller tap ved salg av eiendeler
281,00k
281,00k
-
-
Kommende arrangementer
AI-innhold kan inneholde feil. Finn ut mer
Google-apper